AIGH Capital Management LLC Quant / Systematic

Location: Baltimore, MD

CIK: 0001835943 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 12, 2021

Total Value: $555M (100.0% shares, 0.0% debt)

Holdings (45)

IWM ISHARES TR 31.0%
Value $172M Shares 750,000 Est. Cost Unrealized
EMCORE CORP 5.6%
Value $31.07M Shares 3,370,153 Est. Cost $5.45 Unrealized
DZSIQ DZS INC 4.0%
Value $22.41M Shares 1,080,205 Est. Cost $17.27 Unrealized
GRTX GALERA THERAPEUTICS INC 3.6%
Value $19.89M Shares 2,022,889 Est. Cost $9.41 Unrealized -13.7%
ASPN ASPEN AEROGELS INC 3.5%
Value $19.62M Shares 655,819 Est. Cost $13.15 Unrealized +55.2%
PDSB PDS BIOTECHNOLOGY CORP 3.4%
Value $18.81M Shares 1,499,149 Est. Cost $7.81 Unrealized 0.0%
CYBEROPTICS CORP 3.3%
Value $18.25M Shares 445,591 Est. Cost $40.96 Unrealized
AVNW AVIAT NETWORKS INC 3.3%
Value $18.18M Shares 554,682 Est. Cost $29.28 Unrealized +19.0%
PLAB PHOTRONICS INC 3.2%
Value $17.84M Shares 1,350,734 Est. Cost $13.08 Unrealized 0.0%
PDFS PDF SOLUTIONS INC 2.9%
Value $16.36M Shares 900,000 Est. Cost $17.92 Unrealized 0.0%
THERATECHNOLOGIES INC 2.6%
Value $14.31M Shares 3,575,733 Est. Cost $3.64 Unrealized
O2MICRO INTERNATIONAL LIMITE 2.4%
Value $13.18M Shares 1,828,199 Est. Cost $9.18 Unrealized
ADAMAS PHARMACEUTICALS INC 2.3%
Value $12.86M Shares 2,435,743 Est. Cost $4.68 Unrealized
SCYX SCYNEXIS INC 2.0%
Value $10.87M Shares 1,476,861 Est. Cost $7.89 Unrealized 0.0%
ANVS ANNOVIS BIO INC 1.9%
Value $10.82M Shares 126,469 Est. Cost $8.39 Unrealized +451.0%
PBYI PUMA BIOTECHNOLOGY INC 1.8%
Value $10.23M Shares 1,114,427 Est. Cost $11.03 Unrealized -8.1%
AVAYA HLDGS CORP 1.7%
Value $9.684M Shares 360,000 Est. Cost $19.15 Unrealized
X4 PHARMACEUTICALS INC 1.7%
Value $9.353M Shares 1,438,899 Est. Cost $6.50 Unrealized
EDAP EDAP TMS S A 1.5%
Value $8.566M Shares 1,208,250 Est. Cost $7.20 Unrealized
AVAYA HLDGS CORP 1.5%
Value $8.07M Shares 300,000 Est. Cost $19.15 Unrealized
BWAY BRAINSWAY LTD 1.4%
Value $7.752M Shares 760,000 Est. Cost $9.03 Unrealized
ONDS ONDAS HLDGS INC 1.4%
Value $7.566M Shares 952,867 Est. Cost $7.86 Unrealized 0.0%
FKWL FRANKLIN WIRELESS CORP 1.3%
Value $7.404M Shares 780,000 Est. Cost $20.46 Unrealized -44.4%
PARATEK PHARMACEUTICALS INC 1.1%
Value $6.293M Shares 922,779 Est. Cost $6.36 Unrealized
ALLENA PHARMACEUTICALS 0.9%
Value $5.2M Shares 4,000,000 Est. Cost $1.33 Unrealized
ALIMERA SCIENCES INC 0.8%
Value $4.56M Shares 501,025 Est. Cost $4.22 Unrealized
WIRELESS TELECOM GROUP INC 0.8%
Value $4.397M Shares 1,080,348 Est. Cost $4.07 Unrealized
BK TECHNOLOGIES CORPORATION 0.8%
Value $4.221M Shares 1,340,000 Est. Cost $3.15 Unrealized
SCPHARMACEUTICALS INC 0.7%
Value $3.924M Shares 642,154 Est. Cost $5.64 Unrealized
ICLN ISHARES TR 0.7%
Value $3.753M Shares 160,000 Est. Cost Unrealized
RFIL RF INDS LTD 0.7%
Value $3.694M Shares 495,037 Est. Cost $7.07 Unrealized 0.0%
HTG MOLECULAR DIAGNOSTICS IN 0.6%
Value $3.556M Shares 612,000 Est. Cost $5.68 Unrealized
ARDS ARIDIS PHARMACEUTICALS INC 0.6%
Value $3.331M Shares 459,261 Est. Cost $6.89 Unrealized -9.4%
PROCESSA PHARMACEUTICALS INC 0.6%
Value $3.17M Shares 387,097 Est. Cost $10.35 Unrealized
YIELD10 BIOSCIENCE INC 0.5%
Value $2.918M Shares 342,000 Est. Cost $12.54 Unrealized
DAIO DATA I O CORP 0.5%
Value $2.849M Shares 418,310 Est. Cost $4.69 Unrealized +26.7%
SYNAPTOGENIX INC 0.5%
Value $2.825M Shares 316,945 Est. Cost $8.91 Unrealized
MDNAF MEDICENNA THERAPEUTICS CORP 0.5%
Value $2.768M Shares 915,000 Est. Cost $4.04 Unrealized -8.5%
HANCOCK JAFFE LABORATORIES I 0.4%
Value $2.383M Shares 346,885 Est. Cost $6.66 Unrealized
EVOKE PHARMA INC 0.4%
Value $2.331M Shares 1,701,185 Est. Cost $1.76 Unrealized
SALARIUS PHARMACEUTICALS INC 0.3%
Value $1.909M Shares 1,800,000 Est. Cost $1.00 Unrealized
IPWR IDEAL PWR INC 0.3%
Value $1.835M Shares 144,347 Est. Cost $10.84 Unrealized 0.0%
CYCLO THERAPEUTICS INC 0.3%
Value $1.808M Shares 350,000 Est. Cost Unrealized
HELIUS MED TECHNOLOGIES INC 0.3%
Value $1.72M Shares 101,214 Est. Cost $17.99 Unrealized
NLS PHARMACEUTICS LTD 0.2%
Value $872K Shares 827,921 Est. Cost Unrealized